What should be done with the documentation of mixed drugs in chemotherapy?

The correct approach to handling documentation of mixed drugs in chemotherapy is to treat them as a "piggy back" without a separate administration code. This method means that when multiple drugs are administered simultaneously in a single infusion, they can be documented in a way that indicates they were part of a combined treatment approach.

The rationale behind this choice is based on the guidelines for chemotherapy administration, which typically allows for the reporting of a single administration code when multiple drugs are infused together unless the coding guidelines specify otherwise. This is done to simplify the billing process and prevent duplicate reporting that doesn't add value to the patient's treatment record.

The context of chemotherapy infusion coding emphasizes the importance of accurately reflecting the services provided without unnecessary complexity, which aligns with recognized coding standards. Therefore, documenting a mixed chemotherapy administration as "piggy back" accurately reflects the clinical scenario while adhering to coding protocols.